Molecular Testing in Metastatic Gastric/GEJ Cancer
3 Ansichten
• 06/30/23
0
0
Einbetten
administrator
Abonnenten
David Ilson, MD, PhD, reflects on the role of molecular testing in the treatment of metastatic gastric/gastroesophageal junction cancer and its impact on prognosis and clinical decision making.
Zeig mehr
Facebook Kommentare
SORT BY-
Beste Kommentare
-
Neueste Kommentare